Physician profile
Mark Schlam
NPI 1750780441
$22,523.09
in general payments reported to CMS, 2019-2025
7 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.60 · 2021: $2,411 · 2022: $3,513 · 2023: $211 · 2024: $190 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,886 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250 · Travel and Lodging: $2,208 · Food and Beverage: $2,058 · Honoraria: $1,000 · Gift: $124 · Entertainment: $23.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,886.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
| Travel and Lodging | $2,207.60 |
| Food and Beverage | $2,057.65 |
| Honoraria | $1,000.00 |
| Gift | $124.00 |
| Entertainment | $23.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $21,338.09 | 2021-2025 | |
| Nobel Biocare USA | $775.30 | 2021 | |
| Kls-Martin L.P. | $195.20 | 2021-2022 | |
| Stryker Corporation | $138.17 | 2022-2023 | Na, Smartlock |
| Axogen | $50.60 | 2020 | |
| Implant Direct Sybron International LLC | $13.13 | 2021 | |
| Geistlich Pharma, North America, INC. | $12.60 | 2024 | Geistlich Bio-Gide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schlam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.